<code id='09D3F931DE'></code><style id='09D3F931DE'></style>

<acronym id='09D3F931DE'></acronym>

<center id='09D3F931DE'><center id='09D3F931DE'><tfoot id='09D3F931DE'></tfoot></center><abbr id='09D3F931DE'><dir id='09D3F931DE'><tfoot id='09D3F931DE'></tfoot><noframes id='09D3F931DE'>

<optgroup id='09D3F931DE'><strike id='09D3F931DE'><sup id='09D3F931DE'></sup></strike><code id='09D3F931DE'></code></optgroup>

<b id='09D3F931DE'><label id='09D3F931DE'><select id='09D3F931DE'><dt id='09D3F931DE'><span id='09D3F931DE'></span></dt></select></label></b><u id='09D3F931DE'></u>

~~<i id='09D3F931DE'><strike id='09D3F931DE'><tt id='09D3F931DE'><pre id='09D3F931DE'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

leisure time

author：Wikipedia 2025-08-07 06:16:57 Page View：36757

Merck — Kena Betancur/Getty Images

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

advertisement

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jack Smith previously got search warrant for Trump's Twitter, new court docs show
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

In same hospitals, Black patients receive fewer opioids than white patients

In same hospitals, Black patients receive fewer opioids than white patients

AdobeInequitiesinhealthcarearepervasive,fromaccesstoqualityofcare,andanewstudyfindsthatcommonopioids

Cancer drug shortages should be causing more outrage

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

For Cytokinetics, FDA rejection of heart drug would help, not hinder

MollyFerguson/STATCytokineticswasfounded26yearsagobuthasnotyetdevelopedadrugsuccessfullytoapproval.T

read more